Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timo Rath

Showing results (91-100 of 128) with videos related to

Pageof 13
Sort By:
Surgical Endoscopy|July 11, 2020
Technical success, resection status, and procedural complication rate of colonoscopic full-wall resection: a pooled analysis from 7 hospitals of different care levelsIrmengard Krutzenbichler, Markus Dollhopf, Helmut Diepolder, et al.
Therapeutic Advances in Gastroenterology|January 28, 2021
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximabSarah Fischer, Sarah Cohnen, Entcho Klenske, et al.
Immunity|December 3, 2013
Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancerKristi Baker, Timo Rath, Magdalena B Flak, et al.
Gastroenterology|July 5, 2021
Targeting of the Tec Kinase ITK Drives Resolution of T Cell-Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative ColitisKristina Lechner, Stefanie Mott, Ragheed Al-Saifi, et al.
Therapeutic Advances in Gastroenterology|December 2, 2024
Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort studySarah Fischer, Moritz Donhauser, Sarah Cohnen, et al.
Gut|June 1, 2018
Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's diseaseHeike Schmitt, Ulrike Billmeier, Walburga Dieterich, et al.
Gastrointestinal Endoscopy|November 8, 2017
Prediction of clinical outcomes in Crohn's disease by using confocal laser endomicroscopy: results from a prospective multicenter studyGian Eugenio Tontini, Jonas Mudter, Michael Vieth, et al.
Gastroenterology|June 17, 2026
TIM3 signaling in effector T cells acts as an immunometabolic switch in the purine degradation pathway to suppress intestinal inflammationAnnkathrin Knauss, Michael Gabel, Cora Kaufmann, et al.
Plos One|May 17, 2018
I-scan optical enhancement for the in vivo prediction of diminutive colorectal polyp histology: Results from a prospective three-phased multicentre trialEntcho Klenske, Steffen Zopf, Clemens Neufert, et al.
Endoscopy|March 24, 2018
Development and validation of the SIMPLE endoscopic classification of diminutive and small colorectal polypsMarietta Iacucci, Cristina Trovato, Marco Daperno, et al.
Pageof 13

Showing results (91-100 of 128) with videos related to

Sort By:
Pageof 13
Surgical Endoscopy|July 11, 2020
Technical success, resection status, and procedural complication rate of colonoscopic full-wall resection: a pooled analysis from 7 hospitals of different care levelsIrmengard Krutzenbichler, Markus Dollhopf, Helmut Diepolder, et al.
Therapeutic Advances in Gastroenterology|January 28, 2021
Long-term effectiveness, safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximabSarah Fischer, Sarah Cohnen, Entcho Klenske, et al.
Immunity|December 3, 2013
Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancerKristi Baker, Timo Rath, Magdalena B Flak, et al.
Gastroenterology|July 5, 2021
Targeting of the Tec Kinase ITK Drives Resolution of T Cell-Mediated Colitis and Emerges as Potential Therapeutic Option in Ulcerative ColitisKristina Lechner, Stefanie Mott, Ragheed Al-Saifi, et al.
Therapeutic Advances in Gastroenterology|December 2, 2024
Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort studySarah Fischer, Moritz Donhauser, Sarah Cohnen, et al.
Gut|June 1, 2018
Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's diseaseHeike Schmitt, Ulrike Billmeier, Walburga Dieterich, et al.
Gastrointestinal Endoscopy|November 8, 2017
Prediction of clinical outcomes in Crohn's disease by using confocal laser endomicroscopy: results from a prospective multicenter studyGian Eugenio Tontini, Jonas Mudter, Michael Vieth, et al.
Gastroenterology|June 17, 2026
TIM3 signaling in effector T cells acts as an immunometabolic switch in the purine degradation pathway to suppress intestinal inflammationAnnkathrin Knauss, Michael Gabel, Cora Kaufmann, et al.
Plos One|May 17, 2018
I-scan optical enhancement for the in vivo prediction of diminutive colorectal polyp histology: Results from a prospective three-phased multicentre trialEntcho Klenske, Steffen Zopf, Clemens Neufert, et al.
Endoscopy|March 24, 2018
Development and validation of the SIMPLE endoscopic classification of diminutive and small colorectal polypsMarietta Iacucci, Cristina Trovato, Marco Daperno, et al.
Pageof 13